A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Bristol-Myers Squibb
Bristol-Myers Squibb
Tianjin Medical University Cancer Institute and Hospital
University of Pittsburgh
St. Jude Children's Research Hospital
University of Kentucky
Sun Yat-sen University
Fundación GECP
Blueprint Medicines Corporation
Sun Yat-sen University
Sun Yat-sen University
Shanghai Pudong Hospital
Sun Yat-sen University
Northwestern University
Northwestern University
UNC Lineberger Comprehensive Cancer Center
Guangzhou Medical University
Shandong Cancer Hospital and Institute
University Hospital, Brest